Covered recipient · General Payments record
NILEM PATEL
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$6,180.28
- Reported across 185 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $467.75 | 16 |
| Travel and Lodging | $4.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $182.35 | 3 |
| Abbott Laboratories | $81.36 | 4 |
| ABBVIE INC. | $44.07 | 3 |
| Amgen Inc. | $30.22 | 1 |
| Gilead Sciences, Inc. | $27.49 | 1 |
| Sandoz Inc. | $25.27 | 1 |
| DEXCOM, INC. | $24.18 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.11 | 1 |
| Averitas Pharma Inc. | $20.55 | 1 |
| Lilly USA, LLC | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.92 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125199220 | CMS |
| Abbott Laboratories | $19.08 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125199222 | CMS |
| Abbott Laboratories | $16.79 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125199224 | CMS |
| Abbott Laboratories | $22.57 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125199226 | CMS |
| ABBVIE INC. | $14.55 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105197638 | CMS |
| ABBVIE INC. | $14.24 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105197640 | CMS |
| ABBVIE INC. | $15.28 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105197642 | CMS |
| Amgen Inc. | $30.22 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115998559 | CMS |
| Averitas Pharma Inc. | $20.55 | 08/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133440760 | CMS |
| Dexcom, Inc. | $24.18 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325911 | CMS |
| Gilead Sciences, Inc. | $27.49 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133770551 | CMS |
| Lilly USA, LLC | $13.15 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135251190 | CMS |
| Medtronic, Inc. | $26.20 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119436241 | CMS |
| Medtronic, Inc. | $4.00 | 02/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119436243 | CMS |
| Medtronic, Inc. | $152.15 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119436245 | CMS |
| Sandoz Inc. | $25.27 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089366061 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.11 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144607885 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.